Chart, Financials, Historical Prices, Industry, Insider, Messages, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Nov-2009
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 24)
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
24-Nov-09Pechala's ReportsLubomir PechalaRIGEL PHARMACEUTICALS INC (RIGL=US) - REPORT FOR ACTIVE TRADERS4$25  View Abstract
23-Nov-09Standard & Poor's Quantitative ReportN/ARigel Pharmaceuticals6$25  View Abstract
23-Nov-09Plunkett Research, Ltd.Jack W. PlunkettBiotechnology & Genetics Industry Market Research and Competitive Analysis 2010569$299  View Abstract
23-Nov-09Plunkett Research, Ltd.Jack W. PlunkettBiotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary)71$199  View Abstract
23-Nov-09ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for RIGL13$25  View Abstract
23-Nov-09Market EdgeN/AMarket Edge Equity Research Report4$10  View Abstract
21-Nov-09Pechala's ReportsLubomir PechalaRIGEL PHARMACEUTICALS INC (RIGL=US) 2-weeks forecast1$10  View Abstract
21-Nov-09Pechala's ReportsFrantisek PechalaRIGEL PHARMACEUTICALS INC (RIGL=US) 12-months forecast1$15  View Abstract
20-Nov-09Ford Investor Services, Inc.N/AValue Graph: RIGEL PHARMACEUT -- RIGL1$4  View Abstract
20-Nov-09Ford Investor Services, Inc.N/AIndustry Value Graph: BMRN , CRXL , NPSP , PGNX , RIGL , ZGEN -- DRUGS3$4  View Abstract
Next 14
Brokerage Reports (Showing 1 to 4 of 4)
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
3-Nov-09Collins Stewart LLCSalveen J. Kochnover CFA3Q09 EPS: Focus Remains on a Potential R788 Partnership6$25  View Abstract
21-Oct-09Collins Stewart LLCSalveen J. Kochnover CFAACR Update on R788 in RA5$10  View Abstract
21-Oct-09Thomson StreetEventsN/ARIGL - Event Transcript of Rigel Pharmaceuticals Inc. conference call, Oct. 20, 2009 / 4:00pm ET9$75  View Abstract
21-Oct-09Thomson StreetEventsN/ARIGL - Event Transcript of Rigel Pharmaceuticals Inc. conference call, Oct. 20, 2009 / 4:00pm ET9$75  View Abstract
Independent Reports (Showing 1 to 10 of 20)
Release
Date [down]		 Contributor Author Title Pages Price More Info
24-Nov-09Pechala's ReportsLubomir PechalaRIGEL PHARMACEUTICALS INC (RIGL=US) - REPORT FOR ACTIVE TRADERS4$25View Abstract
23-Nov-09Standard & Poor's Quantitative ReportN/ARigel Pharmaceuticals6$25View Abstract
23-Nov-09Plunkett Research, Ltd.Jack W. PlunkettBiotechnology & Genetics Industry Market Research and Competitive Analysis 2010569$299View Abstract
23-Nov-09Plunkett Research, Ltd.Jack W. PlunkettBiotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary)71$199View Abstract
23-Nov-09ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for RIGL13$25View Abstract
23-Nov-09Market EdgeN/AMarket Edge Equity Research Report4$10View Abstract
21-Nov-09Pechala's ReportsLubomir PechalaRIGEL PHARMACEUTICALS INC (RIGL=US) 2-weeks forecast1$10View Abstract
21-Nov-09Pechala's ReportsFrantisek PechalaRIGEL PHARMACEUTICALS INC (RIGL=US) 12-months forecast1$15View Abstract
20-Nov-09Ford Investor Services, Inc.N/AValue Graph: RIGEL PHARMACEUT -- RIGL1$4View Abstract
20-Nov-09Ford Investor Services, Inc.N/AIndustry Value Graph: BMRN , CRXL , NPSP , PGNX , RIGL , ZGEN -- DRUGS3$4View Abstract
Next 10

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.